Fresenius Medical Care is showing signs of life, up to $20 (0.55%)

A 3 day downtrend is ongoing for Fresenius Medical Care. A possible reversal detected from yesterday; generally flat but with a slight bullish bias, Fresenius Medical Care ranged between $19.68 and $20 before closing higher at $20.

At the same time, United States New Home Sales (Jan) came out at 670,000, while a consensus of analysts was expecting 620,000. United States Core PCE Price Index (MoM) (Jan) released yesterday at 13:30 UTC with a figure of 0.6, while the previous figure was 0.4. United States CFTC S&P 500 speculative net positions came out at -222,300.

Fresenius Medical Care AG & Co. KGaA could be slowing down soon as it approaches resistance at $20.08. Of course, crossing it might suggest further gains are ahead. Despite posting gains on yesterday, Fresenius Medical Care slid below its 10 day Simple Moving Average at $19.95 during the last session — an early indicator that a negative trend could be emerging. Despite this, 'Bullish Harami' is a candlestick chart indicator used for detecting reversals in an existing bear trend. It is generally indicated by a small price increase that's contained within a broader downward price movement and is commonly associated with a bearish trend coming to an end.

Fresenius Medical Care is likely to reverse course and start pointing downward in the short term.

Fresenius Medical Care went up yesterday, yet these health care stocks did not follow — Abbott Laboratories went down to $100.46, losing 2.04% after it closed at $102.55 yesterday. Eli Lilly and Company closed at $321.64 (down 1.8%).

The stock has been trending positively for about 2 months. This year has been a bright one for the kidney dialysis specialist after trading as low as $12.81 and going on to appreciate by 24.19% year to date.